Professional Summary
Professional Overview
Timothy Moore is an accomplished Chief Technology Officer with extensive experience in the biopharmaceutical industry. He specializes in leading complex technical operations and driving innovative solutions to advance pharmaceutical development and manufacturing.
Experience Summary
Current Role
As the Chief Technology Officer at Allogene Therapeutics, Timothy is responsible for overseeing the company's technology strategy, implementation, and optimization. He leads a team of technical experts to ensure the seamless integration of cutting-edge technologies and processes, enabling Allogene to maintain its position as a leader in the field of allogeneic cell therapy.
Career Progression
Prior to his current role, Timothy served as the Chief Operating Officer at Instil Bio, where he was instrumental in the company's successful transition and growth. Before that, he held the position of President and Chief Operations Officer at PACT Pharma, where he played a pivotal role in driving the company's technological advancements and operational excellence.
Timothy's extensive industry experience also includes his tenure as the Executive Vice President at Kite Pharma, where he spearheaded the development and implementation of complex manufacturing and supply chain strategies. Earlier in his career, he served as the SVP Global Head of Technical Operations - Biologics at Genentech, where he demonstrated his expertise in leading large-scale biopharmaceutical operations.
Academic Background
Timothy holds a Bachelor of Science degree in Chemical Engineering from the University of California, Berkeley, and a Master of Science degree in Bioengineering from the University of California, San Diego.
Areas of Expertise
- Biopharmaceutical process development and optimization
- Large-scale manufacturing and technical operations management
- Regulatory compliance and quality assurance
- Cross-functional team leadership and strategic planning
- Innovative technology integration and digital transformation
Professional Impact
Throughout his career, Timothy has made significant contributions to the biopharmaceutical industry. He has led the successful implementation of cutting-edge technologies, streamlined manufacturing processes, and driven operational excellence, resulting in improved efficiencies and accelerated product development timelines. His industry expertise and collaborative approach have been instrumental in advancing the field of cell therapy and contributing to the development of life-changing therapies.
Conclusion
With his extensive technical expertise, proven leadership abilities, and a deep understanding of the biopharmaceutical landscape, Timothy is well-positioned to continue driving innovation and delivering tangible results as the Chief Technology Officer at Allogene Therapeutics. His commitment to excellence and his track record of driving positive change make him a valuable asset to the industry.
